The Foods and Drug Administration initially accepted the injectable medication for managing diabetic issues in 2017; the agency approved a drug with a better dose on the Energetic component in copyright, called semaglutide, to deal with weight problems in 2021, beneath the manufacturer title Wegovy. Considering that then, talk on the drug has poppe